INSIGHTS ON DRUG DEVELOPMENT

• Cell Culture Media Demystified For Performance, Quality, And Innovation

  Cell culture media isn’t one-size-fits-all. Learn how media composition, customization, and analytics can dramatically improve cell growth, productivity, and product quality for complex processes.

• Aggregate Analysis Of Semaglutide

  Effective size exclusion chromatography (SEC) for Semaglutide aggregate analysis is possible without high organic solvents or acidic modifiers. Learn about this robust method for improved efficacy.

• Drug Substance For Early Clinical Phase Initiation

  Explore how proactive nitrosamine impurity risk assessment protects early clinical drug supply, minimizes development delays, and enables confident progression to first‑in‑human studies.

• Overview Of Hot Melt Extrusion And Its Pharmaceutical Applications

  More than 40% of NCEs face aqueous solubility challenges. Here, we examine how hot melt extrusion addresses solubility, modified release, abuse deterrence, and scale-up across pharmaceutical development.

• From Lipids To Launch: End-To-End Therapy Development

  8/20/2026

  Explore integrated capabilities spanning lipid manufacturing, nanoparticle formulation, and more with support designed to move complex therapies from preclinical development through commercialization.

• This Is Where Quality Starts

  3/20/2026

  Quality takes shape long before a workcell ships. Meet the people and processes that ensure consistent performance through every stage of development, and explore how to build reliability into each step.

• The Body As A Bioreactor – Delivering The Vision

  8/8/2026

  Making the body a bioreactor requires precise delivery to selected cells. See how lipid nanoparticles, manufacturing science, and biology are converging to overcome biological barriers and improve the targeting of advanced therapies.

• Immuno-Oncology Biomarker Measurement With High Sensitivity And Speed

  9/17/2024

  Explore results demonstrating the successful use of innovative ELISA assays to detect three key biomarkers: Programmed Death Ligand 1 (PD-L1), Interleukin-8 (IL-8), and Interferon Gamma (IFN-γ).

• Unified Lab Software For Modern QC Workflows

  8/17/2026

  Manage increasingly complex chromatography workflows with a scalable data system that supports secure data management, instrument control, analysis, reporting, and high-resolution characterization.